Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma

BACKGROUND: Epigenetic modification regulates various aspects of cancer biology, from tumor growth and invasion to immune microenvironment modulation. Whether epigenetic regulators (EGRs) can decide tumor malignant degree and risk of immune evasion in liver hepatocellular carcinoma (LIHC) remains un...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Jialiang, Wu, Suiyi, Zhang, Feng, Dai, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330038/
https://www.ncbi.nlm.nih.gov/pubmed/35911718
http://dx.doi.org/10.3389/fimmu.2022.952413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330038/
https://www.ncbi.nlm.nih.gov/pubmed/35911718
http://dx.doi.org/10.3389/fimmu.2022.952413

Ejemplares similares